https://doi.org/10.1186/1471-2172-8-1
P
Peter Newham
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
3.3K
Citations
24
h-index
30
i10-index
Peter Newham is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Cell Adhesion Molecules Research & Immune Response and Inflammation & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 24, co-authored 46 publications.
ORCID: 0000-0002-0955-4080Papers by this author
worksTranscriptional profiling of the LPS induced NF-κB response in macrophages
2007 · BMC Immunology · 490 citations
The evolving role of investigative toxicology in the pharmaceutical industry
2023 · Nature Reviews Drug Discovery · 215 citations
https://doi.org/10.1038/s41573-022-00633-x
Compensatory ion transport buffers daily protein rhythms to regulate osmotic balance and cellular physiology
2021 · Nature Communications · 61 citations
https://doi.org/10.1038/s41467-021-25942-4
Analysis of Ligand-Induced and Ligand-Attenuated Epitopes on the Leukocyte Integrin α4β1: VCAM-1, Mucosal Addressin Cell Adhesion Molecule-1, and Fibronectin Induce Distinct Conformational Changes
1998 · The Journal of Immunology · 36 citations
https://doi.org/10.4049/jimmunol.160.9.4508
Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNFα polyclonal immune ovine Fab similar to D-CytoFab
2011 · Critical Care · 2 citations
https://doi.org/10.1186/cc9682
AZD9773, a novel anti-TNFα immune Fab in development for severe sepsis and septic shock: demonstration of safety and efficacy in a murine CLP sepsis model
2011 · Critical Care · 0 citations
https://doi.org/10.1186/cc10410
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat